HR 2001 increases annual funding for a grant program supporting dental workforce development from $13.9 million to $15 million, extending the program through fiscal years 2026-2030 (previously 2019-2023) under the Public Health Service Act. The bill modifies existing funding levels to maintain support for addressing dental workforce shortages, with funds remaining available until expended. This change directly affects the operation of the grant program and its ability to fund dental workforce initiatives.
The My Body, My Data Act of 2025 requires companies and services handling personal reproductive or sexual health information - such as health apps, clinics, or digital platforms - to only collect, retain, or share this data when strictly necessary for a service a person has requested. It gives individuals the right to access, correct, or delete their data easily (within 15 days, without fees), and mandates clear privacy policies explaining how data is used. The bill also prohibits companies from retaliating against people who exercise these rights, such as by charging higher prices or denying services. Enforcement will be handled by the Federal Trade Commission, with individuals able to sue for violations and seek penalties of up to $1,000 per violation per day.
The CHARGE Act of 2025 establishes a $50 million annual grant program (2026-2030) to fund solar energy systems and energy storage technologies at Federally Qualified Health Centers (FQHCs). Eligible recipients - including FQHCs, state/local governments, or nonprofits representing FQHCs - can use grants to install renewable energy systems or receive technical assistance for their design and operation. The program, administered by the Department of Energy, directly supports community health centers in improving energy resilience and reducing operating costs. It specifically targets FQHCs serving underserved populations, as defined under the Social Security Act.
This bill expands Medicare's definition of "rural emergency hospital" to allow certain closed rural hospitals to rejoin the program. Specifically, it creates a new eligibility category for facilities that were critical access hospitals or rural hospitals (under Section 1886(d)) in rural counties, ceased operations between January 2014 and December 2020, and submit an application to become rural emergency hospitals. The bill modifies Medicare payment rules to provide specific adjustments for these reactivated facilities, including distance requirements (e.g., hospitals within 35 miles of another hospital won't receive immediate payment increases). The changes take effect January 1, 2027, directly affecting rural hospitals that closed during the specified period and wish to rejoin Medicare.
The Thalidomide Survivors Compensation Act of 2025 would establish a federal program to provide $150,000 in compensation to U.S. citizens or permanent residents who suffered birth defects from thalidomide exposure in utero during the 1950s-1960s. To qualify, individuals must submit documentation of exposure and injury by May 31, 2034, and the compensation would be tax-exempt and not count toward income calculations for means-tested welfare programs. The Department of Health and Human Services would administer the program, with an annual review process to evaluate its effectiveness and make adjustments as needed. The bill acknowledges approximately 100 U.S. thalidomide survivors remain alive today, facing ongoing medical needs without formal compensation, while 46 countries already provide such support to affected individuals.
This bill creates a 50% tax credit for individuals purchasing qualified mobility devices, such as wheelchairs, walkers, canes, braces, or prosthetics. The credit applies to costs paid after the bill's enactment, covers up to three devices per year, and prevents double benefits by reducing other deductions for the same expenses. It directly affects people who buy these devices for mobility needs, allowing them to claim the credit on their federal income tax returns. The credit is designed to offset out-of-pocket costs for essential mobility equipment.
The FASD Respect Act (S 139) establishes a federal program within the Public Health Service Act to improve support for individuals with fetal alcohol spectrum disorders (FASD) and their families. It creates FASD Centers for Excellence to expand diagnostic capacity, develop culturally appropriate interventions, and build state/Tribal partnerships for prevention, screening, and treatment. The law requires funding for public awareness campaigns, training for healthcare and social service professionals, and a national directory of FASD resources. This directly affects individuals with FASD, their families, healthcare providers, and state/Tribal health programs through new federal grants and coordination requirements.
This bill (HR 6868) streamlines the FDA review process for over-the-counter (OTC) drugs by requiring the agency to use the "least burdensome" approach when evaluating manufacturer requests to add new products to standardized OTC safety guidelines. It mandates that the FDA meet with companies if existing data is insufficient, provide written recommendations for necessary studies, and document these meetings in the public administrative record. The bill directly affects drug manufacturers seeking to market new OTC products, reducing review barriers without changing safety standards or altering the criteria for FDA approval. This focuses on improving efficiency in the regulatory process for OTC drug innovations.
HR 6652, the "U.S. Vets of the FAS Act," requires the Department of Veterans Affairs (VA) to provide telehealth services and mail-order pharmacy deliveries to veterans residing in the Freely Associated States (FAS) - which include the Marshall Islands, Micronesia, and Palau. The bill mandates the VA to establish agreements with FAS governments within one year of enactment and begin offering these services within the same timeframe. It also modifies travel payment rules to require VA to cover beneficiary travel costs starting one year after enactment. The VA must report quarterly on implementation progress and costs to Congress until agreements are finalized and services launched. This bill directly affects veterans in FAS territories and VA operations related to their healthcare access.
This bill amends the Higher Education Act to require colleges and universities receiving federal funds to implement evidence-based programs preventing alcohol and substance misuse among students and staff, replacing outdated terms like "drug abuse" with "substance misuse." It establishes a $15 million annual grant program (2027-2031) to fund recovery support services, integrated mental health and substance use care, overdose prevention, and campus-wide crisis response training. Institutions must certify compliance with these programs and report on implementation to Congress. The law directly affects all eligible higher education institutions, mandating updated prevention frameworks and collaboration with health agencies.
